Sight Sciences

United States
New Lisbon, Wisconsin, United States, 94025

Company profile

Sight Sciences company profile

Sight Sciences is a medical device company that uses a computer-based device designed for the treatment of eye disease. Sight Sciences' devices and non-invasive dry eye products are used for glaucoma procedures or in combination with cataract surgery using the same clear corneal incision, assisting ophthalmologists and optometrists to address the underlying physiology of ophthalmic disease. The company's non-surgical Dry Eye product portfolio consists of TearCare which is now commercially available for both ophthalmologists and optometrists. TearCare is a software-controlled, wearable eyelid technology that delivers highly targeted and adjustable heat to the meibomian glands of the eyelids for conditions such as meibomian gland dysfunction and dry eye. It was founded in 2011 and is headquartered in Menlo Park, California, United States.

Business identity

Contact email
[email protected]
Phone number
877-266-1144
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$50,000+
Founded
2011-01-01, Year

Headquarters

Postal code
94025
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
8
Total equity funding
$108.7M
Last funding
Post IPO Debt / $35M / 2024-01-23
Last equity funding
Series Unknown / $23.2M
Investors
7
Lead investors
6
Founders
2
Articles
153
Exited on
2021-07-15

Founders and investors

Founders

David BadawiPaul Badawi

Lead investors

Allegro Investment FundD1 Capital PartnersHercules CapitalHicks Equity PartnersKCKScientific Health Development Partners

Investors

D1 Capital PartnersHercules CapitalKCKMidCap FinancialScientific Health Development Partners